Increased use of biocidal agents in the environment
Halt in research for other infectious diseases
Unlicensed use of some agents
Self-medication fuelled by the media covers and demand of potential treatments (i.e., hydroxychloroquine)
Drug (especially narrow spectrum antimicrobials) and personal protective equipment shortages
Increased rate of empirical antimicrobial treatment for respiratory illness
Overcrowding and overloading of healthcare systems
|
Increased focus on hand hygiene
Social distancing
Reduced travel
Decreased incidence of infections due to social distancing, enhanced hygiene, disinfection and other protective measures
Public’s attention focused on infectious diseases
Introduction of novel biomarkers (i.e., procalcitonin)
Overall decreased antimicrobial consumption due to fewer patient consultations
Reduction of critically ill patient transfer between countries
|